Hyposmia: Clinical Trials

4 trials for Hyposmia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 11Completed 1

Follow Hyposmia: new trials by email Literature Review of Hyposmia trials Research Report on Hyposmia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of CYR-064 Versus Placebo in Patients.
CYR-064 - Hyposmia
Phase 2CompletedCyrano Therapeutics, Inc.1512023-09-262026-08-31
Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
Stellate Ganglion Block - Anosmia, Hyposmia
Phase 1 / Phase 2CompletedWashington University School of Medicine202022-09-012026-02-12
Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction
Gabapentin gelatin capsules 300mg, Placebo - COVID-19, Olfactory Disorder
Phase 2CompletedWashington University School of Medicine682022-01-102025-03-04
Smell in Covid-19 and Efficacy of Nasal Theophylline
Theophylline Powder, Placebo Comparator - Covid19, Anosmia
Phase 2CompletedWashington University School of Medicine512021-03-152023-05-24

Narrower conditions

Anosmia (4)  ·  COVID-19 (3)  ·  Olfaction Disorders (3)  ·  Ageusia (1)

Broader conditions

Nervous System Diseases (4)  ·  Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Sensation Disorders (4)  ·  Signs and Symptoms (4)  ·  Coronaviridae Infections (3)  ·  Coronavirus Infections (3)  ·  Infections (3)  ·  Lung Diseases (3)  ·  Nidovirales Infections (3)  ·  Pneumonia (3)  ·  Pneumonia, Viral (3)  ·  RNA Virus Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)

Interventions

Mepivacaine (1)

Sponsors

Washington University School of Medicine (3)  ·  Cyrano Therapeutics, Inc. (1)

Countries

United States (4)

Top investigators

Jay F Piccirillo, M.D., FACS (1)  ·  Jay F Piccirillo, MD (1)  ·  Mas Takashima, MD (1)

Results publications

PMID 18377764, PMID 19359985, PMID 21191261, PMID 22377744, PMID 23165381, PMID 23731850, PMID 27923495, PMID 35797024, PMID 37733356